Skin Sensitisation (Modified Draize-95 Test)
MDT-95
Skin Sensitisation Test (Modified Draize-95) to Support a Low Dermatitis Potential Claim
1 other identifier
interventional
208
1 country
1
Brief Summary
Skin Sensitization Test (Modified Draize-95) to Support a Low Dermatitis Potential Claim for a Powder Free Polychloroprene Surgical Gloves, Sterile. To evaluate whether residual chemical additives at a level on the gloves that may induce type IV allergy to the unsensitized general user population when using polychloroprene based surgical gloves
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Nov 2019
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 23, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 20, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
April 6, 2020
CompletedFirst Submitted
Initial submission to the registry
May 20, 2020
CompletedFirst Posted
Study publicly available on registry
May 26, 2020
CompletedJune 17, 2020
June 1, 2020
3 months
May 20, 2020
June 15, 2020
Conditions
Outcome Measures
Primary Outcomes (2)
Induction Phase
Irritation scored by Erythemal Scoring Scale, Basic Score - Description: 0 - No visible reaction. 0.5 - Doubtful or Negligible Erythema Reaction. 1.0 - Mild or just perceptible macular erythema reaction in a speckled / follicular, patchy or confluent pattern (slight pinking). 2.0 - Moderate erythema reaction in a confluent pattern (definite redness). 3.0 - Strong or brisk erythema reaction that may spread beyond the test site.
24 days
Challenge Phase
Irritation scored by Erythemal Scoring Scale, Basic Score - Description : 0 - No visible reaction. 0.5 - Doubtful or Negligible Erythema Reaction. 1.0 - Mild or just perceptible macular erythema reaction in a speckled / follicular, patchy or confluent pattern (slight pinking). 2.0 - Moderate erythema reaction in a confluent pattern (definite redness). 3.0 - Strong or brisk erythema reaction that may spread beyond the test site.
48 hours
Study Arms (1)
Device and Control
EXPERIMENTALDevice: Powder Free Polychloroprene Surgical Gloves, Sterile. Low Dermatitis Potential, Tested for use with Chemotherapy Drugs. Approximately 2cm x 2cm square positioned to ensure that the inside portion of the test material maintained skin contact. Positive Control: 0.4% Sodium Lauryl Sulfate (SLS) Dose. 0.2 ml
Interventions
Approximately 2cm x 2cm square positioned to ensure that the inside portion of the test material maintained skin contact.
Eligibility Criteria
You may qualify if:
- The test subjects are normal volunteers who have documented informed consent and have not participated in other voluntary testing for at least 30 days.
- Age of the test subjects ranged from 18 to 65 years.
- Efforts are made to provide racial and gender diversity of the test subjects that reasonably reflects the general user population in the US
You may not qualify if:
- The test subjects with any visible skin disease that might be confused with skin reactions caused by the test material.
- The test subjects with any indication of existing Type I allergy to natural rubber proteins.
- The test subjects who have used corticosteroids, either systemically or topically on the potential test site, two weeks before testing.
- Test subjects who have received endogenous or exogenous immunosuppressive treatments (or prolonged sun exposure).
- All subjects who are pregnant or become pregnant during the study.
- All lactating women,
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Makmal Bioserasi & Klinikal, Healthmedic Research Sdn. Bhd.
Kuala Lumpur, Cheras, 56000, Malaysia
Related Publications (3)
Foy V, Weinkauf R, Whittle E, Basketter DA. Ethnic variation in the skin irritation response. Contact Dermatitis. 2001 Dec;45(6):346-9. doi: 10.1034/j.1600-0536.2001.450605.x.
PMID: 11846750RESULTKompaore F, Tsuruta H. In vivo differences between Asian, black and white in the stratum corneum barrier function. Int Arch Occup Environ Health. 1993;65(1 Suppl):S223-5. doi: 10.1007/BF00381346.
PMID: 8406931RESULTRobinson MK. Population differences in acute skin irritation responses. Race, sex, age, sensitive skin and repeat subject comparisons. Contact Dermatitis. 2002 Feb;46(2):86-93. doi: 10.1034/j.1600-0536.2002.460205.x.
PMID: 11918601RESULT
Related Links
Study Officials
- STUDY DIRECTOR
Dr. Saadiah Sulaiman, Dermatologist, MBBCh, MMED
Makmal Bioserasi & Klinikal, Healthmedic Research Sdn. Bhd.
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 20, 2020
First Posted
May 26, 2020
Study Start
November 23, 2019
Primary Completion
February 20, 2020
Study Completion
April 6, 2020
Last Updated
June 17, 2020
Record last verified: 2020-06
Data Sharing
- IPD Sharing
- Will not share